NEW YORK, Sept. 24, 2024
NEW YORK, Sept. 24, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape- The global kidney stones therapeutic market size is estimated to grow by USD 537.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 4.96% during the forecast period. Growing popularity of flexible digital ureteroscopes is driving market growth, with a trend towards advances in technologies in kidney stones treatment. However, decreasing number of urologists coupled with shortage of skilled surgeons poses a challenge. Key market players include Anvik Biotech, Aristo Pharma GmbH, Bausch Health Companies Inc., Bayer AG, Biomedix Siomond Pharma, Cipla Inc., Cmg Biotech Pvt. Ltd., Dr Reddys Laboratories Ltd., Emcure Pharmaceuticals Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson Services Inc., Macleods Pharmaceuticals Ltd., Medinova Diagnostic Services Ltd., Mission Pharmacal Co., Nostrum Pharmaceuticals LLC, Pfizer Inc., Walter Bushnell, Windlas Biotech Pvt. Ltd., and Worth Medicines Pvt. Ltd.
Advertisement
AI-Powered Market Evolution Insights. Our comprehensive market report ready with the latest trends, growth opportunities, and strategic analysis- View your snapshot now
Advertisement
Forecast period
2024-2028
Base Year
2023
Historic Data
2018 - 2022
Segment Covered
End-user (Hospitals, Specialty clinics, and Ambulatory surgical centers), Type (Lithotripsy, Ureteroscopy, and Percutaneous nephrolithonomy (PCNL)), and Geography (North America, Europe, Asia, and Rest of World (ROW))
Region Covered
North America, Europe, Asia, and Rest of World (ROW)
Key companies profiled
Anvik Biotech, Aristo Pharma GmbH, Bausch Health Companies Inc., Bayer AG, Biomedix Siomond Pharma, Cipla Inc., Cmg Biotech Pvt. Ltd., Dr Reddys Laboratories Ltd., Emcure Pharmaceuticals Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson Services Inc., Macleods Pharmaceuticals Ltd., Medinova Diagnostic Services Ltd., Mission Pharmacal Co., Nostrum Pharmaceuticals LLC, Pfizer Inc., Walter Bushnell, Windlas Biotech Pvt. Ltd., and Worth Medicines Pvt. Ltd.
Key Market Trends Fueling Growth
The kidney stones therapeutic market has witnessed significant advancements in the past three decades, driven by technological innovations in kidney stones treatment procedures. Lithotripsy, URS, and percutaneous techniques have revolutionized the field, replacing conventional open surgical treatments. Holmium laser technology has been a game-changer, enabling efficient stone removal with minimal tissue damage. Thulium fiber lasers, with their tunable wavelength and smaller beam diameter, offer additional advantages. Miniaturized PCNL procedures and the combination of ultrasonic and pneumatic lithotriptors further enhance treatment efficacy. Disposable ureteroscopes address the limitations of reusable ones, improving patient access to URS and reducing hospital costs. These technological advancements are expected to fuel the growth of the global kidney stones therapeutics market.
The Kidney Stones Therapeutic Market is experiencing significant growth due to increasing stone therapy results and the rising elderly population. However, a lack of awareness and inadequate healthcare infrastructure pose challenges. Startups are entering the scene with innovative product lines, including endoscopy equipment for urolithiasis treatment and neuromodulation devices for preventing stone formation. Contractual agreements between healthcare providers and manufacturers are driving increased investments in kidney stone disease treatments. Key trends include minimally invasive procedures, such as interventional cardiology and urology, as well as advanced technologies like laser systems, fibers, and accessories. Companies like Olympus Corporation are leading the way with offerings in calcium-oxalate, cysteine, uric acid, and struvite stone treatments. Imaging technologies like abdominal x-ray, computed tomography, ultrasound, abdominal MRI, and intravenous pyelography continue to play crucial roles in diagnosis and treatment. Overall, the market is focused on improving outcomes and efficiencies in kidney stone management, with a focus on Ureterolithiasis and Nephrolithiasis.
Insights on how AI is driving innovation, efficiency, and market growth- Request Sample!
Market Challenges
Insights into how AI is reshaping industries and driving growth- Download a Sample Report
Segment Overview
This kidney stones therapeutic market report extensively covers market segmentation by
1.1 Hospitals- Lithotripsy is a non-invasive outpatient treatment for kidney stones up to 20 mm in diameter, located in the kidney and not in the ureters or bladder. This procedure uses focused sound waves to break the stone from outside the body, making it less invasive and associated with less discomfort than URS and PCNL. EDAP TMS, based in France, offers the Sonolith i-sys lithotripter, which can treat stones up to 210 mm in depth and is suitable for obese patients. The system is DICOM compatible, ensuring easy data transfer, and offers protection for medical staff. Despite a lower success rate and higher likelihood of re-treatments compared to URS and PCNL, lithotripsy's non-invasive nature continues to drive its use. However, treatment guidelines often recommend URS over lithotripsy for ureteric stones, limiting lithotripsy's adoption and market growth, resulting in moderate expansion during the forecast period.
Download complimentary Sample Report to gain insights into AI's impact on market dynamics, emerging trends, and future opportunities- including forecast (2024-2028) and historic data (2018 - 2022)
Research Analysis
Kidney stones, also known as urolithiasis, affect millions worldwide. The primary types include calcium oxalate, cysteine, uric acid, and struvite stones. Diagnosis involves methods such as abdominal x-ray, computed tomography (CT), ultrasound, abdominal MRI, and intravenous pyelography. Olympus Corporation's endoscopes facilitate minimally invasive procedures like ureteroscopic lithotripsy and percutaneous renal lithotomy for calcium oxalate stones. MIS procedures, including extracorporeal shock wave lithotripsy, offer advantages over open surgeries in terms of side effects and recovery time. Lifestyle factors, such as fast food consumption and cooking practices, contribute to the development of kidney stones. Ureterolithiasis, or stones in the ureter, can lead to severe pain and complications if left untreated.
Market Research Overview
Kidney Stones Therapeutic Market: Overview The Kidney Stones Therapeutic Market is a significant segment of the Urolithiasis market, focusing on the treatment and management of kidney stones. Kidney stones, also known as nephrolithiasis or urolithiasis, are solid crystalline mineral deposits that form in the kidneys. The most common types of kidney stones are calcium oxalate, cysteine, uric acid, and struvite. Diagnosis of kidney stones typically involves imaging techniques such as abdominal x-ray, computed tomography (CT), ultrasound, abdominal MRI, intravenous pyelography, and urography. Olympus Corporation's Olympus Corporation's ureteroscopy and endoscopy systems are widely used for diagnosing and treating kidney stones. Treatment options for kidney stones include medications, minimally invasive procedures, and surgical interventions. Shock wave lithotripsy (SWL) is a non-invasive procedure that uses high-energy shock waves to break down kidney stones. Ureteroscopy and percutaneous renal lithotomy are minimally invasive surgical procedures used for removing larger stones. Open surgeries, such as nephrolithotomy, are used for removing very large stones. The market for kidney stone therapeutics is driven by the increasing prevalence of kidney stone disease, particularly in the elderly population, and the lack of awareness and healthcare infrastructure in developing countries. The high cost of treatment, side effects of medications, and the increasing use of minimally invasive procedures are key trends in the market. Innovation in medical devices, such as Olympus Corporation's OptiVision technology and Dornier MedTech's Dornier Delta III imaging system, and digital health solutions, such as telemedicine and dietary interventions, are expected to drive growth in the market. Companies such as Stryker, Allengers, Medispec, EDAP TMS, Sonomotion, Dornier MedTech, Endoluxe, and others are investing in new product lines and contractual agreements to expand their presence in the market. Key challenges in the market include the high cost of treatment, side effects of medications, and the need for specialized surgical expertise. The market is expected to grow significantly in the coming years due to increased investments in research and development, innovation in medical devices, and the increasing prevalence of kidney stone disease. Fast food consumption and cookware materials, such as aluminum and copper, which increase the risk of calcium oxalate stones, are also contributing factors to the market growth. The market for kidney stone therapeutics is expected to continue to evolve with the development of new technologies, medications, and diagnostic tools. In conclusion, the Kidney Stones Therapeutic Market is a dynamic and growing segment of the healthcare industry, driven by the increasing prevalence of kidney stone disease, innovation in medical devices and digital health solutions, and the need for effective and minimally invasive treatment options. The market is expected to continue to grow significantly in the coming years, driven by increasing awareness, innovation, and investments in research and development.
1 Executive Summary2 Market Landscape3 Market Sizing4 Historic Market Size5 Five Forces Analysis6 Market Segmentation
7 Customer Landscape8 Geographic Landscape9 Drivers, Challenges, and Trends10 Company Landscape11 Company Analysis12 Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200Email: [email protected]: www.technavio.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/kidney-stones-therapeutics-market-to-increase-by-usd-537-8-million-2024-2028-driven-by-flexible-digital-ureteroscopes-and-ai-trendstechnavio-report-302256611.html
SOURCE Technavio
